Scientific Teams

The Scientific Teams at Ashvattha Therapeutics focus on advancing the development of hydroxyl dendrimer therapeutics (HDTs) through rigorous research and preclinical studies. They collaborate across disciplines such as chemistry, translational biology, and regulatory affairs to identify and validate new HDT candidates, ensure compliance with regulatory standards, and support clinical trial readiness for treating oncology, ophthalmology, and inflammatory diseases.